Home › Lupus › Missouri › St. Louis
Lupus clinical trials in St. Louis, MO
5 studies for Lupus are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- and 1 more
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
RecruitingPhase 1
- Research Site, St Louis
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
RecruitingPhase 1/2
- Research Site, St Louis
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RecruitingPhase 1
- Washington University School of Medicine, St Louis
Lupus Landmark Study: A Prospective Registry and Biorepository
RecruitingObservational study
- Washington University, St Louis
About Lupus
Lupus is an autoimmune disease that causes your immune system to attack your healthy tissues and cells. This can cause damage to many parts of your body.
More about Lupus on MedlinePlus
Lupus trials in other cities
- New York City, NY18 studies
- Houston, TX12 studies
- Durham, NC12 studies
- Washington, DC10 studies
- Miami, FL10 studies
- Philadelphia, PA9 studies
- Tampa, FL9 studies
- Santa Monica, CA8 studies
- Boston, MA8 studies
- Chicago, IL8 studies
- Los Angeles, CA8 studies
- Clearwater, FL8 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer71 studies
- Breast Cancer64 studies
- Metastatic Cancer53 studies
- Colorectal Cancer49 studies
- Prostate Cancer47 studies
- Cancer (all types)47 studies
- Lung Cancer39 studies
- Ovarian Cancer37 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.